AAAAAA
Results: 1-25/62
Authors:
OBOYLE KP
SENTER PD
BHARGAVA K
CHUN S
ANTHONY G
MARKOWITZ AL
WADLER S
Citation: Kp. Oboyle et al., EFFECTS OF A HYBRID RECOMBINANT HUMAN ALPHA-INTERFERON (A D) ON IN-VITRO CYTOTOXICITY AND IN-VIVO LOCALIZATION OF MONOCLONAL-ANTIBODY L6-CYTOSINE DEAMINASE CONJUGATE IN A COLON-CANCER MODEL/, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 33-42
Authors:
WADLER S
HAYNES H
ROZENBLIT A
HU XP
KALEYA R
WIERNIK PH
Citation: S. Wadler et al., SEQUENTIAL PHASE-II TRIALS OF FLUOROURACIL AND INTERFERON BETA(SER) WITH OR WITHOUT SARGRAMOSTIM IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, The cancer journal from Scientific American, 4(5), 1998, pp. 331-337
Authors:
WADLER S
ATKINS M
KARP D
NEUBERG D
HAYNES H
DUTCHER JP
Citation: S. Wadler et al., CLINICAL-TRIAL OF WEEKLY INTENSIVE THERAPY WITH 5-FLUOROURACIL ON 2 DIFFERENT SCHEDULES COMBINED WITH INTERFERON ALPHA-2A AND FILGRASTIM INPATIENTS WITH ADVANCED SOLID TUMORS - EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY P-Z991, The cancer journal from Scientific American, 4(4), 1998, pp. 261-268
Authors:
METZGER R
DANENBERG K
LEICHMAN CG
SALONGA D
SCHWARTZ EL
WADLER S
LENZ HJ
GROSHEN S
LEICHMAN L
DANENBERG PV
Citation: R. Metzger et al., HIGH BASAL LEVEL GENE-EXPRESSION OF THYMIDINE PHOSPHORYLASE (PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR) IN COLORECTAL TUMORS IS ASSOCIATED WITH NONRESPONSE TO 5-FLUOROURACIL, Clinical cancer research, 4(10), 1998, pp. 2371-2376
Authors:
WADLER S
Citation: S. Wadler, COMBINED RADIATION AND CHEMOTHERAPY FOR CARCINOMA OF THE ANAL-CANAL -THE STAFFORD MARTENSON ARTICLE REVIEWED/, Oncology, 12(3), 1998, pp. 382
Authors:
WADLER S
BENSON AB
ENGELKING C
CATALANO R
FIELD M
KORNBLAU SM
MITCHELL E
RUBIN J
TROTTA P
VOKES E
Citation: S. Wadler et al., RECOMMENDED GUIDELINES FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED DIARRHEA, Journal of clinical oncology, 16(9), 1998, pp. 3169-3178
Authors:
BEITLER JJ
SMITH RV
SILVER CE
QUISH A
DEORE SM
MULLOKANDOV E
FONTELA DP
WADLER S
HAYES MK
VIKRAM B
Citation: Jj. Beitler et al., CLOSE OR POSITIVE MARGINS AFTER SURGICAL RESECTION FOR THE HEAD AND NECK-CANCER PATIENT - THE ADDITION OF BRACHYTHERAPY IMPROVES LOCAL-CONTROL, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 313-317
Authors:
BEITLER JJ
SMITH RV
HAYNES H
SILVER CE
QUISH A
KOTZ T
SERRANO M
BROOK A
WADLER S
Citation: Jj. Beitler et al., A PHASE-I CLINICAL-TRIAL OF PROLONGED INFUSION OF HYDROXYUREA IN COMBINATION WITH HYPERFRACTIONATED, ACCELERATED, EXTERNAL RADIATION-THERAPY IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCER OF THE HEAD AND NECK, Investigational new drugs, 16(2), 1998, pp. 161-169
Authors:
EINZIG AI
WIERNIK PH
WADLER S
KAPLAN J
BENSON LT
TENTORAMANO L
TAN V
Citation: Ai. Einzig et al., PHASE-I STUDY OF PACLITAXEL (TAXOL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN PATIENTS WITH UNRESECTABLE MALIGNANCY, Investigational new drugs, 16(1), 1998, pp. 29-36
Authors:
JONES TH
WADLER S
HUPART KH
Citation: Th. Jones et al., ENDOCRINE-MEDIATED MECHANISMS OF FATIGUE DURING TREATMENT WITH INTERFERON-ALPHA, Seminars in oncology, 25(1), 1998, pp. 54-63
Authors:
WADLER S
HOROWITZ R
ZHANG HY
SCHWARTZ EL
Citation: S. Wadler et al., EFFECTS OF PERTURBATIONS OF POOLS OF DEOXYRIBONUCLEOSIDE TRIPHOSPHATES ON EXPRESSION OF RIBONUCLEOTIDE REDUCTASE, A G(1) S TRANSITION-STATEENZYME, IN P53-MUTATED CELLS/, Biochemical pharmacology, 55(9), 1998, pp. 1353-1360
Authors:
WADLER S
BAJAJ R
NEUBERG D
AGARWAL V
HAYNES H
BENSON AB
Citation: S. Wadler et al., PROGNOSTIC IMPLICATIONS OF C-KI-RAS2 MUTATIONS IN PATIENTS WITH ADVANCED COLORECTAL-CANCER TREATED WITH 5-FLUOROURACIL AND INTERFERON - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (EST-2292), The cancer journal from Scientific American, 3(5), 1997, pp. 284-288
Authors:
HOROWITZ RW
HEERDT BG
HU XP
SCHWARTZ EL
WADLER S
Citation: Rw. Horowitz et al., COMBINATION THERAPY WITH 5-FLUOROURACIL AND IFN-ALPHA-2A INDUCES A NONRANDOM INCREASE IN DNA FRAGMENTS OF LESS-THAN-3 MEGABASES IN HT29-COLON-CARCINOMA CELLS, Clinical cancer research, 3(8), 1997, pp. 1317-1322
Authors:
MAKOWER D
WADLER S
HAYNES H
SCHWARTZ EL
Citation: D. Makower et al., INTERFERON INDUCES THYMIDINE PHOSPHORYLASE PLATELET-DERIVED ENDOTHELIAL-CELL GROWTH-FACTOR EXPRESSION IN-VIVO/, Clinical cancer research, 3(6), 1997, pp. 923-929
Authors:
COMERCI JT
HALLAM S
GOLDBERG GL
RUNOWICZ CD
FIELDS AL
WADLER S
GALLAGHER RE
Citation: Jt. Comerci et al., EXPRESSION OF RETINOIC ACID RECEPTOR-BETA-2 MESSENGER-RNA IN NORMAL CERVICAL EPITHELIUM AND CERVICAL SQUAMOUS-CELL CARCINOMA, International journal of oncology, 11(5), 1997, pp. 983-988
Authors:
KRUGLYAK E
FREEMAN LM
WADLER S
Citation: E. Kruglyak et al., DETECTION OF OCCULT GASTRIC-CARCINOMA WITH IN-111 LABELED CYT-103 (ONCOSCINT) IMMUNOSCINTIGRAPHY, Annals of oncology, 8(3), 1997, pp. 301-302
Authors:
WADLER S
SCHWARTZ EL
Citation: S. Wadler et El. Schwartz, ROLE OF INTERFERON AS A MODULATOR OF FLUOROPYRIMIDINES - REPLY TO A RECENT EDITORIAL, Annals of oncology, 8(2), 1997, pp. 139-140
Authors:
ZHANG HY
WADLER S
Citation: Hy. Zhang et S. Wadler, MICROPREPARATION OF CULTURED-CELLS FOR IN-SITU REVERSE TRANSCRIPTION PCR, BioTechniques, 22(4), 1997, pp. 618
Authors:
SWAIN SM
WHALEY FS
GERBER MC
WEISBERG S
YORK M
SPICER D
JONES SE
WADLER S
DESAI A
VOGEL C
SPEYER J
MITTELMAN A
REDDY S
PENDERGRASS K
VELEZGARCIA E
EWER MS
BIANCHINE JR
GAMS RA
Citation: Sm. Swain et al., CARDIOPROTECTION WITH DEXRAZOXANE FOR DOXORUBICIN-CONTAINING THERAPY IN ADVANCED BREAST-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1318-1332
Authors:
BEITLER JJ
ANDERSON PS
WADLER S
RUNOWICZ CD
HAYES MK
FIELDS AL
SOOD B
GOLDBERG GL
Citation: Jj. Beitler et al., PELVIC EXENTERATION FOR CERVIX CANCER - WOULD ADDITIONAL INTRAOPERATIVE INTERSTITIAL BRACHYTHERAPY IMPROVE SURVIVAL, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 143-148
Authors:
LEAF AN
NEUBERG D
SCHWARTZ EL
WADLER S
RITCH PS
DUTCHER JP
ADAMS GL
Citation: An. Leaf et al., AN ECOG PHASE-II STUDY OF AMONAFIDE IN UNRESECTABLE OR RECURRENT CARCINOMA OF THE HEAD AND NECK (PB390), Investigational new drugs, 15(2), 1997, pp. 165-172
Authors:
AUGENLICHT LH
WADLER S
CORNER G
RICHARDS C
RYAN L
MULTANI AS
PATHAK S
BENSON A
HALLER D
HEERDT BG
Citation: Lh. Augenlicht et al., LOW-LEVEL C-MYC AMPLIFICATION IN HUMAN COLONIC-CARCINOMA CELL-LINES AND TUMORS - A FREQUENT, P53-INDEPENDENT MUTATION ASSOCIATED WITH IMPROVED OUTCOME IN A RANDOMIZED MULTIINSTITUTIONAL TRIAL, Cancer research, 57(9), 1997, pp. 1769-1775
Authors:
WADLER S
SCHWARTZ EL
HAYNES H
RAMEAU R
QUISH A
MANDELI J
GALLAGHER R
HALLAM S
FIELDS A
GOLDBERG G
MCGILL F
JENNINGS S
WALLACH RC
RUNOWICZ CD
Citation: S. Wadler et al., ALL-TRANS-RETINOIC ACID AND INTERFERON-ALPHA-2A IN PATIENTS WITH METASTATIC OR RECURRENT CARCINOMA OF THE UTERINE CERVIX - CLINICAL AND PHARMACOKINETIC STUDIES, Cancer, 79(8), 1997, pp. 1574-1580
Authors:
HOROWITZ RW
ZHANG HY
SCHWARTZ EL
LADNER RD
WADLER S
Citation: Rw. Horowitz et al., MEASUREMENT OF DEOXYURIDINE TRIPHOSPHATE AND THYMIDINE TRIPHOSPHATE IN THE EXTRACTS OF THYMIDYLATE SYNTHASE-INHIBITED CELLS USING A MODIFIED DNA-POLYMERASE ASSAY, Biochemical pharmacology, 54(5), 1997, pp. 635-638
Authors:
WADLER S
GLEISSNER B
HILGENFELD RU
THIEL E
HAYNES H
KALEYA R
ROZENBLIT A
KREUSER ED
Citation: S. Wadler et al., PHASE-II TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA), 5-FLUOROURACIL AND RECOMBINANT INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED GASTRIC-CARCINOMA, European journal of cancer, 32A(7), 1996, pp. 1254-1256